Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
TEVA PHARMACEUTICAL INDUSTRIES (NY: TEVA)
54.47 USD  +0.07 (+0.13%)
Official Closing Price  /  Updated: 4:15 PM EDT, Jul 25, 2014  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,055,493
Open 54.25
Bid (Size) 54.49 (600)
Ask (Size) 54.50 (100)
Prev. Close 54.40
Today's Range 54.00 - 54.55
52wk Range 36.26 - 55.36
Shares Outstanding 851,000,000
Dividend Yield 0.64%
Performance
YTD
+35.30%
+35.30%
1 Month
+3.57%
+3.57%
3 Month
+5.87%
+5.87%
6 Month
+20.22%
+20.22%
1 Year
+34.20%
+34.20%
Top News
More News
Financial Results, Campaign Launch, and New Steps in Facility Planning - Research Reports on Johnson & Johnson, Merck, AstraZeneca, Novartis and Teva
July 23, 2014
Editor Note: For more information about this release, please scroll to bottom Read More
from PR Newswire
Teva Completes Acquisition of Labrys: Opens Door to a Strong and Novel Migraine Prevention and Treatment Franchise within its CNS Portfolio
July 21, 2014
from Business Wire News Releases
More News
Read More
Teva to Report Second Quarter 2014 Financial Results on July 31, 2014
July 18, 2014
from Business Wire News Releases
Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin
July 17, 2014
from PR Newswire
Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders’ Meeting Proposals
July 16, 2014
from Business Wire News Releases
7 High-Dividend Stocks With Low Risk
July 24, 2014
category NYSE:WFC , NYSE:XOM , NASDAQ:MSFT , and 7 more.
from InvestorPlace » Stock Picks
7 High-Dividend Stocks With Low Risk
July 24, 2014
category NYSE:WFC , NASDAQ:MSFT , NYSE:XOM , and 7 more.
from InvestorPlace - Latest Headlines
UPDATE 1-Abuse of U.S. generic-drug rules costs billions -report
July 23, 2014
category companyNews
from Reuters: Company News
Abuse of U.S. generic-drug rules costs consumers billions, report says
July 23, 2014
category companyNews
from Reuters: Company News
Teva Announces FDA Acceptance of NDA Filing for Investigational Short-Acting Beta-Agonist (SABA) Inhaler (Albuterol MDPI)
July 14, 2014
from Business Wire News Releases
Teva completes deal for second migraine-treatment developer
July 21, 2014
category Pharmaceuticals , Endo International , Mergers and Acquisitions , and 6 more.
from Business Journals
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here